Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Ending Cash Position : د.إ232 Mil (As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

What is Gulf Pharmaceutical Industries PSC Ending Cash Position?

Gulf Pharmaceutical Industries PSC's Ending Cash Position for the quarter that ended in Dec. 2023 was د.إ232 Mil.

Gulf Pharmaceutical Industries PSC's quarterly Ending Cash Position increased from Jun. 2023 (د.إ169 Mil) to Sep. 2023 (د.إ184 Mil) and increased from Sep. 2023 (د.إ184 Mil) to Dec. 2023 (د.إ232 Mil).

Gulf Pharmaceutical Industries PSC's annual Ending Cash Position declined from Dec. 2021 (د.إ143 Mil) to Dec. 2022 (د.إ86 Mil) but then increased from Dec. 2022 (د.إ86 Mil) to Dec. 2023 (د.إ232 Mil).

Gulf Pharmaceutical Industries PSC Ending Cash Position Historical Data

The historical data trend for Gulf Pharmaceutical Industries PSC's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gulf Pharmaceutical Industries PSC Ending Cash Position Chart

Gulf Pharmaceutical Industries PSC Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

58.80

73.70

143.00

86.40

231.60

Gulf Pharmaceutical Industries PSC Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Ending Cash Position	Get a 7-Day Free Trial															86.40	110.00	168.80	183.90	231.60

Gulf Pharmaceutical Industries PSC Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Gulf Pharmaceutical Industries PSC's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	88.4	+	143.2
	=	232

Gulf Pharmaceutical Industries PSC's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	185.9	+	45.7
	=	232

Gulf Pharmaceutical Industries PSC Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Gulf Pharmaceutical Industries PSC's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

Airport Road, P.O. Box 997, Digdaga, Ras Al Khaimah, ARE

Website

https://www.julphar.net

Gulf Pharmaceutical Industries PSC is a generic pharmaceutical manufacturer in the Middle East and North Africa. The company manufactures and sells pharmaceuticals and medical compounds, including cosmetics compounds, and drugs. It operates in four segments: Manufacturing, Planet, Investments, and others. It maintains a diverse product portfolio that targets various therapeutic segments including Gastrointestinal Tract (GIT), Respiratory, Pain Management, Wounds & Scars, Anti-infectives, Anemia, Gynecology, Dermatology, Erectile Dysfunction, and Cardiology. The geographical segments are UAE, Other GCC countries, and Other countries.

Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Headlines

No Headlines